Deutsche Bank Ag\ Biogen Inc. Call Options Transaction History

Deutsche Bank Ag\

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2021 May 13, 2021	SELL	$242.95 - $284.63 $8,503 - $9,962	-35 Reduced 74.47%	12 $3,000
Q1 2020 May 14, 2020	SELL	$268.85 - $341.04 $20,701 - $26,260	-77 Reduced 62.1%	47 $15,000
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $300,502 - $337,042	-1,382 Reduced 91.77%	124 $28,000
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $105,697 - $116,509	482 Added 47.07%	1,506 $351,000
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $49,409 - $77,282	-228 Reduced 18.21%	1,024 $241,000
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $111,400 - $141,100	400 Added 46.95%	1,252 $376,000
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $202,121 - $285,866	777 Added 1036.0%	852 $233,000
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $21,086 - $24,726	75	75 $23,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.